SPY328.79+2.27 0.70%
DIA266.72+2.37 0.90%
IXIC10,902.80+157.52 1.47%

H.C. Wainwright Reiterates Buy on Marinus Pharmaceuticals, Raises Price Target to $6

H.C. Wainwright analyst Douglas Tsao reiterates Marinus Pharmaceuticals (NASDAQ:MRNS) with a Buy and raises the price target from $5 to $6.

Benzinga · -

H.C. Wainwright analyst Douglas Tsao reiterates Marinus Pharmaceuticals (NASDAQ:MRNS) with a Buy and raises the price target from $5 to $6.